PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+9.02%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.15B
AUM Growth
-$149M
(-11%)
Cap. Flow
-$228M
Cap. Flow
% of AUM
-19.74%
Top 10 Holdings %
Top 10 Hldgs %
54.46%
Holding
82
New
17
Increased
13
Reduced
24
Closed
24
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$20.8M |
| 2 |
Natera
NTRA
|
$17.1M |
| 3 |
Cencora
COR
|
$16M |
| 4 |
Masimo
MASI
|
$15.9M |
| 5 |
Akero Therapeutics
AKRO
|
$14.2M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$61.6M |
| 2 |
AbbVie
ABBV
|
$54M |
| 3 |
Elevance Health
ELV
|
$38.4M |
| 4 |
argenx
ARGX
|
$34M |
| 5 |
Universal Health Services
UHS
|
$29.2M |
Sector Composition
| 1 | Healthcare | 96.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
-126,989
| Closed | -$61.6M |
|
77
Xenon Pharmaceuticals
XENE
$2.99B
| – | – |
-92,236
| Closed | -$3.09M |
|
78
Health Care Select Sector SPDR Fund
XLV
$33.8B
| – | – |
0
| – | – |
|
79
Metagenomi
MGX
$67.2M
| – | – |
-885,803
| Closed | -$1.2M |
|
|
BOLD
80
Boundless Bio
BOLD
$25.7M
| – | – |
-240,513
| Closed | -$363K |
|